Dimensional Fund Advisors
ORKA

Dimensional Fund Advisors’s Oruka Therapeutics ORKA Stock Holding History

Dimensional Fund Advisors’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.8M Buy
113,176
+167
+0.1% +$11.1K ﹤0.01% 2269
2026
Q1 		$5.54M Buy
+113,009
New +$3.93M ﹤0.01% 2466
2024
Q3 		– Sell
-3,542
Closed -$163K – 3397
2024
Q2 		$163K Hold
3,542
– – ﹤0.01% 3195
2024
Q1 		$75.7K Sell
3,542
-1
-0% -$20 ﹤0.01% 3294
2023
Q4 		$72.3K Hold
3,543
– – ﹤0.01% 3311
2023
Q3 		$85.5K Buy
3,543
+1
+0% +$24 ﹤0.01% 3333
2023
Q2 		$86.3K Hold
3,542
– – ﹤0.01% 3346
2023
Q1 		$84.6K Buy
+3,542
New +$93.3K ﹤0.01% 3325
2022
Q3 		$88K Hold
3,542
– – ﹤0.01% 3354
2022
Q2 		$106K Hold
3,542
– – ﹤0.01% 3326
2022
Q1 		$98K Hold
3,542
– – ﹤0.01% 3396
2021
Q4 		$91K Buy
+3,542
New +$107K ﹤0.01% 3447

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Dimensional Fund Advisors's ORKA Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Oruka Therapeutics (ORKA) stake by 0.15% in Q2 2026, buying an estimated $11.1K and bringing the position to 113,176 shares worth $10.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2269.

Dimensional Fund Advisors first reported a position in ORKA in Q4 2021 and has held it in 12 quarters since. 256 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Dimensional Fund Advisors held 113,176 shares of Oruka Therapeutics worth $10.8M as of Q2 2026.
  • Dimensional Fund Advisors bought 167 Oruka Therapeutics shares in Q2 2026, an estimated $11.1K.
  • Oruka Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2269 holding.
  • Dimensional Fund Advisors first reported a position in Oruka Therapeutics in Q4 2021 and has held it in 12 quarters since.
  • 256 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.